Morningstar, Inc.
MORN
$209.86
-4.15%
Morningstar, Inc. is a leading provider of independent investment research, data, and technology solutions for financial advisors, asset managers, and individual investors, operating within the financial data and stock exchanges industry. The company differentiates itself through its trusted brand, comprehensive data platforms like Morningstar Direct and PitchBook, and a broad suite of products spanning data, research, and wealth management solutions. Currently, the stock is attracting attention due to its robust revenue growth, driven by strong demand for its data and software platforms, and a recent surge in share price following a period of volatility, as investors weigh its long-term growth prospects against a backdrop of market uncertainty and evolving investor needs.…
MORN
Morningstar, Inc.
$209.86
Investment Opinion: Should I buy MORN Today?
Rating: Hold. Morningstar is a quality company with steady revenue growth and improving margins, but the current valuation leaves limited upside. The consensus 'Buy' rating and average target of $236.67 imply an 8.7% upside, which is modest given the risks. The thesis is that the company's strong fundamentals justify a premium, but the market has already priced in much of the growth.
Sign up to view all
MORN 12-Month Price Forecast
The AI assessment is neutral, as the stock's valuation is not compelling enough to be bullish, but the fundamentals are solid enough to avoid a bearish stance. The key factor is whether Morningstar can deliver the earnings growth implied by its forward PE. If revenue growth accelerates and margins expand, the stock could re-rate higher, but if growth disappoints, the multiple could compress. The analyst consensus is positive, but the limited coverage and high PEG ratio warrant caution. A upgrade to bullish would require evidence of accelerating growth, while a downgrade to bearish would occur if margins deteriorate or revenue growth falls below 5%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Morningstar, Inc.'s 12-month outlook, with a consensus price target around $236.67 and implied upside of +12.8% versus the current price.
Average Target
$236.67
0 analysts
Implied Upside
+12.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$220 - $260
Analyst target range
Morningstar has coverage from 3 analysts, with a consensus recommendation of 'Buy' and an average target price of $236.67. This implies an upside of approximately 8.7% from the current price of $217.65. The target range is $220 to $260, with the low target suggesting a modest 1.1% upside, while the high target implies a 19.5% upside. The consensus is bullish, but the small number of analysts limits the robustness of the signal. Recent ratings have been positive, with BMO Capital reiterating 'Outperform' in February 2026 and UBS maintaining a 'Buy' in October 2025, indicating sustained institutional confidence. The relatively narrow target range (18% spread) suggests moderate conviction among analysts, but the limited coverage may lead to less efficient price discovery.
Bulls vs Bears: MORN Investment Factors
Morningstar presents a mixed picture: strong revenue growth and margin expansion are offset by a high valuation and significant underperformance relative to the market. The bull case is supported by consistent revenue growth, improving profitability, and a diversified business model, while the bear case highlights the expensive valuation, high debt, and limited analyst coverage. Currently, the evidence slightly favors the bull case, as the company's fundamentals are solid and the stock has rebounded strongly from its 52-week low. The most important tension is whether the market will continue to reward Morningstar's growth with a premium multiple, or if valuation concerns will cap upside. If revenue growth remains above 8% and margins continue to expand, the stock could re-rate higher; conversely, any disappointment in earnings could trigger a sharp correction.
Bullish
- Consistent Revenue Growth: Morningstar's revenue has grown steadily, with Q4 2025 revenue of $641.1 million, an 8.5% year-over-year increase. This marks the fourth consecutive quarter of sequential growth, from $581.9 million in Q1 2025 to $641.1 million in Q4 2025, indicating strong demand for its data and research services.
- Expanding Profit Margins: Operating margin improved to 24.9% in Q4 2025, up from 20.7% in Q3 2025 and 19.6% in Q1 2025. This margin expansion, driven by operating leverage, has contributed to a 30% year-over-year increase in EPS to $2.84 in Q4 2025.
- Strong Balance Sheet: Morningstar maintains a healthy financial position with a debt-to-equity ratio of 1.15 and a current ratio of 0.99, indicating adequate liquidity to meet short-term obligations. The company generated $442.6 million in free cash flow over the trailing twelve months, providing ample flexibility for investments and shareholder returns.
- Analyst Consensus Buy: With a consensus recommendation of 'Buy' and an average target price of $236.67, analysts see an 8.7% upside from the current price of $217.65. Recent ratings from BMO Capital (Outperform) and UBS (Buy) reinforce institutional confidence in the company's growth trajectory.
Bearish
- High Valuation Relative to Growth: The trailing PE of 24.3x and forward PE of 15.6x imply an expected earnings growth of over 50%, which is aggressive. The PEG ratio of 7.25x suggests the stock is expensive relative to its growth rate, leaving little room for error.
- Significant Underperformance vs. Market: Over the past year, Morningstar's stock is down 16.7%, while the S&P 500 gained 18.6%. This underperformance of 35.2 percentage points indicates a loss of investor confidence and potential structural challenges.
- Limited Analyst Coverage: With only 3 analysts covering the stock, the consensus signal is weak. The narrow target range ($220-$260) suggests moderate conviction, but the small sample size limits the reliability of the average target price.
- High Debt Levels: The debt-to-equity ratio of 1.15 indicates a leveraged balance sheet, which could increase financial risk if interest rates rise or cash flows decline. Interest expenses of $11.4 million in Q4 2025 represent a meaningful drag on profitability.
MORN Technical Analysis
Morningstar's stock has experienced a significant recovery from its 52-week low of $141.49, currently trading at $217.65, which is approximately 82.5% of its 52-week range (with a high of $263.67). Over the past year, the stock is down 16.7%, indicating a longer-term downtrend, but the recent price action suggests a strong rebound. The stock's beta of 0.98 indicates it moves in line with the broader market, providing no additional volatility cushion. The 1-year price change of -16.7% contrasts sharply with the S&P 500's +18.6% gain, highlighting significant underperformance, yet the stock is now trading well above its lows, suggesting a potential trend reversal.
Beta
0.98
0.98x market volatility
Max Drawdown
-50.5%
Largest decline past year
52-Week Range
$141-$262
Price range past year
Annual Return
-20.0%
Cumulative gain past year
| Period | MORN Return | S&P 500 |
|---|---|---|
| 1m | +9.0% | +2.0% |
| 3m | +16.1% | +1.0% |
| 6m | +10.5% | +11.8% |
| 1y | -20.0% | +18.1% |
| ytd | -0.3% | +11.7% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MORN Fundamental Analysis
Morningstar's revenue has been growing steadily, with the most recent quarter (Q4 2025) reporting revenue of $641.1 million, an 8.5% year-over-year increase. This growth is consistent with the prior quarters: Q3 2025 revenue was $617.4 million, Q2 2025 was $605.1 million, and Q1 2025 was $581.9 million, showing a clear upward trajectory. The company's revenue is diversified across asset-based ($90.2 million), licensed-based ($437.8 million), and transaction-based ($113.1 million) segments, with licensed-based being the largest driver. This steady growth indicates strong demand for Morningstar's data and research services, supporting a positive investment case.
Quarterly Revenue
$641100000.0B
2025-12
Revenue YoY Growth
+8.5%
YoY Comparison
Gross Margin
61.1%
Latest Quarter
Free Cash Flow
$442600000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MORN Overvalued?
Given that Morningstar is profitable, the PE ratio is the most appropriate valuation metric. The trailing PE is 24.3x, while the forward PE is 15.6x, indicating that the market expects significant earnings growth. The gap between trailing and forward PE suggests an expected earnings increase of over 50%, which is aggressive but may be justified by the company's recent margin expansion and revenue growth. The PEG ratio of 7.25x is high, implying that the stock is expensive relative to its growth rate, but this may be due to the low growth rate used in the calculation.
PE
24.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~86x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Morningstar carries a debt-to-equity ratio of 1.15, indicating a leveraged balance sheet that could strain cash flows if interest rates rise. Interest expenses of $11.4 million in Q4 2025 represent a meaningful cost, and the current ratio of 0.99 suggests tight liquidity. Revenue growth, while steady at 8.5% YoY, is not explosive, and the company's reliance on licensed-based revenue (68% of total) exposes it to client budget cuts in a downturn. The high payout ratio of 20.6% and dividend yield of 0.84% offer limited income support, and any earnings miss could pressure the stock given its premium valuation.
FAQ
The key risks include: 1) Financial risk from high debt (debt-to-equity of 1.15) and interest expenses, which could strain cash flows if rates rise. 2) Competitive risk from larger players like Bloomberg and MSCI, which could pressure pricing and market share. 3) Macro risk from a market downturn, as the stock's beta of 0.98 offers no downside protection. 4) Company-specific risk from limited analyst coverage, which could lead to inefficient price discovery. The most severe risk is a revenue growth deceleration, which would likely trigger a de-rating of the stock's multiple.
The 12-month forecast is moderately positive. The base case (50% probability) sees the stock trading around $236.67, the analyst average target, implying an 8.7% upside. The bull case (30% probability) targets $260, a 19.5% gain, if growth accelerates. The bear case (20% probability) sees the stock falling to $160-180, a 17-26% loss, if growth disappoints. The most likely scenario is the base case, assuming revenue growth remains around 8-10% and margins stay stable.
Morningstar's valuation is mixed. The trailing PE of 24.3x is above the market average, but the forward PE of 15.6x suggests the market expects significant earnings growth. The PEG ratio of 7.25x indicates the stock is expensive relative to its growth rate, which is a red flag. Compared to peers, the stock trades at a premium, reflecting its strong brand and market position. The market is pricing in a 50% earnings increase, which may be optimistic. Overall, the stock appears fairly valued to slightly overvalued, with limited margin of safety.
Morningstar is a good stock to buy for investors with a long-term horizon who value steady growth and a strong brand. The stock offers an 8.7% upside to the analyst average target of $236.67, which is modest but positive. However, the high PEG ratio of 7.25x suggests the stock is not cheap, and the limited analyst coverage adds uncertainty. The biggest downside risk is a slowdown in revenue growth, which could lead to multiple compression. For investors seeking growth at a reasonable price, MORN may not be the best fit, but for those who appreciate its defensive qualities and consistent performance, it could be a solid addition to a diversified portfolio.
Morningstar is better suited for long-term investment, given its steady growth and strong competitive position. The stock's beta of 0.98 means it moves with the market, offering no short-term trading advantage. The dividend yield of 0.84% is low, providing minimal income. The company's earnings visibility is moderate, with revenue growth driven by recurring subscriptions. A minimum holding period of 3-5 years is recommended to allow the growth story to play out and to ride out short-term volatility. Short-term traders may find limited opportunities due to the stock's relatively low volatility and lack of clear catalysts.